SCHEMBL4597982

SCHEMBL4597982

Cc1cccc([C@H](CO)NC(=O)O)c1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 1/20 0.50
RIPK1 Q13546 1/20 0.48
AURKA O14965 1/20 0.45
CDK2 P24941 1/20 0.45
ACP3 P15309 1/20 0.45
GPR139 Q6DWJ6 1/20 0.44
CTSA P10619 3/20 0.43
GPR88 Q9GZN0 1/20 0.43
ROCK2 O75116 2/20 0.42
SLC6A9 P48067 1/20 0.42
SLC6A5 Q9Y345 1/20 0.42
EPHX2 P34913 2/20 0.41
USP1 O94782 1/20 0.41
WDR48 Q8TAF3 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14393517 0.89 CYP26A1 (0.46) CYP26A1RIPK1AURKACDK2ACP3
SCHEMBL29918436 0.89 CYP26A1 (0.46) CYP26A1RIPK1AURKACDK2ACP3
SCHEMBL4580573 0.87 CYP26A1 (0.50) CYP26A1ACP3GPR139CTSAEPHX2
SCHEMBL14338245 0.86 KCNA5 (0.46) CYP26A1RIPK1AURKACDK2GPR139
SCHEMBL18765697 0.86 CYP26A1 (0.47) CYP26A1RIPK1AURKACDK2GPR139
SCHEMBL29675785 0.86 CYP26A1 (0.47) CYP26A1RIPK1AURKACDK2GPR139
SCHEMBL16783311 0.83 KYNU (0.45) RIPK1CDK2GPR88ROCK2EPHX2
SCHEMBL3446408 0.83 MAPK1 (0.51) RIPK1AURKACDK2ACP3CTSA
SCHEMBL4596498 0.83 MAPK1 (0.51) RIPK1AURKACDK2ACP3CTSA
SCHEMBL15996210 0.83 ROCK2 (0.48) RIPK1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1924265-A2 CHEMOKINE RECEPTOR BINDING COMPOUNDS Genzyme Corporation (US) 2008-05-28 EP disclosed
WO-2007022371-A2 CHEMOKINE RECEPTOR BINDING COMPOUNDS GENZYME CORPORATION (US) 2007-02-22 WO disclosed